Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04015167 · ClinicalTrials.gov registry record
A Post-Market Clinical Evaluation of the Treatment of Tibia Fractures With the T2 Alpha Tibia Nailing System
A clinical trial of Tibial Fractures, sponsored by Stryker Trauma and Extremities.
- Completed
- Registry status
- 103
- Enrollment target
- 4
- Study locations
NCT04015167: Completed study of Tibial Fractures, sponsored by Stryker Trauma and Extremities.
NCT04015167 is a study of Tibial Fractures that has completed, run by Stryker Trauma and Extremities. The registered enrollment target is 103 participants, below the 332-participant average among 12 other Tibial Fractures trials with a reported enrollment target (69% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04015167, a study of Tibial Fractures, has completed, sponsored by Stryker Trauma and Extremities.
- COMPLETED
- Registry status
- 103 participants
- Enrollment target
- 4
- Study locations
Study Summary
This investigation is a prospective, multi-center clinical investigation. It is anticipated that a total of 80 subjects will be enrolled. Neither subjects nor investigators are blinded to treatment and the clinical investigation includes a historical control which will be compared to the T2 Alpha Tibia Nailing System. Total duration of enrollment, 12 month follow-up and analysis is expected to take 31 months. The clinical investigation has been designed to follow the surgeon's standard of care for tibia fractured subjects, in addition to a 12 month follow-up visit. The primary endpoint of this clinical investigation is to confirm efficacy/performance at 12 months, as measured by the SF-36 Physical Component Summary (PCS). Confirmation of efficacy/performance at 12 months will be based on an equal or higher (non-inferior) SF-36 Physical Component Summary (PCS) result of the T2 Alpha Tibia Nailing System compared to the benchmark literature.
Primary Outcome
The primary endpoint of this clinical investigation is to confirm efficacy/performance at 12 months, as measured by the SF-36 PCS (36-Item Short Form Health Survey Physical Component Summary). The SF-36 PCS is a self-report measure of health status. SF-36 Physical Component Summary scores range from 0 to 100; higher SF-36 score results are linked to better subject results. Confirmation of efficacy/performance at 12 months will be based on an equal or higher (non-inferior) SF-36 Physical Compone
Conditions Studied
Interventions
- DEVICE T2 Alpha Tibia Nailing System
Study Locations (4)
Minnesota
- St. Cloud Orthopedic Associates, Ltd - Sartell
New York
- New York University - New York
Ohio
- UC Health - Cincinnati
Virginia
- Inova Fairfax Medical Campus - Falls Church
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2019-09-12 |
| Est. Completion | 2023-08-08 |
What the finished NCT04015167 record still lists
NCT04015167 is an observational study that tracks outcomes without assigning an intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 332-participant average among 12 other Tibial Fractures trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Tibial Fractures appearing as the primary indexed condition, and to 1 intervention - of which T2 Alpha Tibia Nailing System is the first listed.
NCT04015167 reports a single indexed study location in Minnesota, New York, Ohio.
Frequently Asked Questions
What is clinical trial NCT04015167 about?
NCT04015167 is a clinical study titled "A Post-Market Clinical Evaluation of the Treatment of Tibia Fractures With the T2 Alpha Tibia Nailing System". This investigation is a prospective, multi-center clinical investigation. It is anticipated that a total of 80 subjects will be enrolled. Neither subjects nor investigators are blinded to treatment and the clinical investigation includes a historical control which will be compared to the T2 Alpha Ti...
What is the current status of trial NCT04015167?
This trial is currently completed. The enrollment target is 103 participants. The study started on 2019-09-12. Estimated completion is 2023-08-08.
What conditions does trial NCT04015167 study?
This clinical trial studies the following conditions: Tibial Fractures.
What interventions are being tested in trial NCT04015167?
The interventions under investigation include: T2 Alpha Tibia Nailing System (DEVICE).
Who is sponsoring clinical trial NCT04015167?
This trial is sponsored by Stryker Trauma and Extremities, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04015167 being conducted?
This trial has 4 study locations across Minnesota, New York, Ohio, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tibial Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04015167's enrollment target sits among peer trials
103 6th of 12 higher than 7 of 12 other Tibial Fractures trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tibial Fractures trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparison of Healing Measures Tibial Fractures Following Standard Intramedullary Nailing or Micromotion Tibial Intramedullary Nailing
RECRUITING · NA
-
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
RECRUITING · Phase 3
-
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
RECRUITING · Phase 4
-
Does Joint Lavage Reduce Intraarticular Inflammation in High-energy Tibial Pilon Fractures?
RECRUITING · NA
-
Intramedullary Calcium Sulfate Antibiotic Depot
RECRUITING · Phase 3
-
Blood Flow Restriction Training in Patients With Lower Extremity Fractures
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI